The neuropathological changes are similar to those seen in persons with AD in the general population (i.e. Amyloid βeta (Aβ) plaques, neurofibrillary tangles of hyperphosphorylated tau protein, and neuroinflammation), but appear decades earlier [[2], [3], [4]]. Here, MAPT is linked to Alzheimer disease.